Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,910 | 32,574 | 40,912 | 46,681 | 53,469 |
| Receivables | 102 | 239 | 321 | 554 | 736 |
| TOTAL | $27,329 | $33,925 | $42,404 | $48,163 | $54,992 |
| Non-Current Assets | |||||
| PPE Net | 16,555 | 15,551 | 13,968 | 10,534 | 7,951 |
| Investments And Advances | 697 | 0 | 0 | 0 | 0 |
| Intangibles | 4,628 | 4,868 | 5,108 | 5,357 | 5,606 |
| TOTAL | $21,880 | $20,419 | $19,076 | $15,891 | $13,556 |
| Total Assets | $49,209 | $54,344 | $61,480 | $64,054 | $68,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 576 | 547 | N/A | 223 | 231 |
| Accounts payable and accrued liabilities | 888 | 1,018 | 2,552 | 831 | 661 |
| Accrued Expenses | 3,216 | 2,604 | 2,675 | 2,625 | 3,085 |
| Other current liabilities | N/A | N/A | 478 | N/A | N/A |
| TOTAL | $8,465 | $10,208 | $10,084 | $8,232 | $6,595 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,816 | 4,516 | N/A | 3,090 | 2,324 |
| Deferred Revenues | 3,786 | 6,040 | 4,380 | 4,553 | 2,619 |
| Other Non-Current Liabilities | 0 | 0 | 4,165 | 0 | 0 |
| TOTAL | $49,575 | $47,501 | $49,234 | $48,123 | $49,155 |
| Total Liabilities | $58,041 | $57,709 | $59,319 | $56,355 | $55,750 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 412 | 412 | 412 | 412 | 412 |
| Common Shares | 74 | 74 | 6 | 74 | 74 |
| Retained earnings | -267,378 | -261,873 | -256,246 | -250,034 | -244,514 |
| Other shareholders' equity | -266 | -228 | -228 | -228 | -228 |
| TOTAL | $-8,832 | $-3,365 | $2,161 | $7,700 | $12,799 |
| Total Liabilities And Equity | $49,209 | $54,344 | $61,480 | $64,054 | $68,549 |